drugset / Trial / NCT00236834

A Study of the Safety and Effectiveness of Levofloxacin Compared With Imipenem/Cilastatin in Patients With Pneumonia Acquired During Hospitalization

NCT00236834

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to compare the safety and effectiveness of levofloxacin with imipenem/cilastatin in the treatment of hospital-acquired pneumonia

Timeline

Start
1997-12
Primary completion
Completion
2001-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Levofloxacin Small molecule 750 mg Intravenous
Subject imipenem/cilastatin Unknown 500 mg Intravenous
Subject imipenem/cilastatin Unknown 1 g Intravenous

Indications